Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy

Toxicology
Rui A CarvalhoKendall B Wallace

Abstract

Doxorubicin (Adriamycin) is a potent and broad-spectrum antineoplastic agent, the clinical utility of which is restricted by a cumulative and progressive cardiomyopathy that develops with repeated dosing. Fundamental to the cardiac failure is an interference with mitochondrial respiration and inhibition of oxidative phosphorylation. Global gene expression arrays in cardiac tissue indicate that inhibition of mitochondrial oxidative phosphorylation by doxorubicin (DOX) is accompanied by a decreased expression of genes related to aerobic fatty acid oxidation and a corresponding increase in expression of genes involved in anaerobic glycolysis, possibly as an alternate source for ATP production. The aim of this investigation was to determine whether this is also manifest at the metabonomic level as a switch in metabolic flux in cardiac tissue, and whether this can be averted by co-administering the cardioprotective drug, dexrazoxane (DZR). (13)C-isotopomer analysis of isolated perfused hearts from male Sprague-Dawley rats receiving 6 weekly s.c. injections of 2mg/kg DOX demonstrated a shift from the preferential oxidation of fatty acids to enhanced oxidation of glucose and lactate plus pyruvate, indicative of a compensatory shift to...Continue Reading

Citations

Nov 26, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Francesco CorradiRaffaele De Caterina
Nov 4, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Alexander StrigunFozia Noor
Aug 27, 2013·La Presse médicale·Marianne MazevetEric Morel
Jan 15, 2016·Cancer·Steven E LipshultzUNKNOWN Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium
Mar 16, 2013·Medicinal Research Reviews·Filipa S CarvalhoPaulo J Oliveira
Sep 10, 2014·Nuclear Medicine and Biology·Etienne CroteauRoger Lecomte
Sep 11, 2013·Free Radical Biology & Medicine·Laura A A GilliamP Darrell Neufer
Apr 3, 2012·Journal of Molecular and Cellular Cardiology·Yanti OctaviaAn L Moens
Mar 10, 2015·The Biochemical Journal·Kyle S McCommis, Brian N Finck
Feb 22, 2012·Journal of Proteomics·Séverine GratiaMalgorzata Tokarska-Schlattner
Nov 12, 2013·Toxicology and Applied Pharmacology·Kendra K S Nordgren, Kendall B Wallace
Aug 30, 2012·ACS Chemical Biology·Amy H HenkinAndreas Stahl
Nov 14, 2018·Cardiovascular Research·Wuqiang ZhuLoren J Field
Dec 12, 2013·American Journal of Physiology. Endocrinology and Metabolism·Xiao M PeiParco M Siu
Oct 1, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kendra K S NordgrenKendall B Wallace
Jan 18, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Joel N MeyerDanielle F Mello
Oct 9, 2019·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Hamdan S Al-MalkyAbdel-Moneim M Osman
Nov 19, 2019·Human & Experimental Toxicology·A H AjzashokouhiG Karimi
Oct 21, 2010·Current Eye Research·A R SantiagoA F Ambrósio
Dec 10, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Cynthia KankeuHeinrich J Huber
Nov 30, 2018·Frontiers in Pharmacology·Canan G Nebigil, Laurent Désaubry
Feb 10, 2019·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Matteo BaucknehtCecilia Marini
Jul 4, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Marcus D DarrabieDanny O Jacobs
Mar 28, 2020·Circulation Research·Kendall B WallacePaulo J Oliveira
Apr 6, 2020·Journal of Cardiovascular Translational Research·Carolyn J ParkGiselle C Meléndez
Jun 6, 2020·Cardiovascular Toxicology·Kendra K S Nordgren, Kendall B Wallace
Oct 27, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chontida YaranaDaret K St Clair
Feb 7, 2021·Current Treatment Options in Oncology·Michele RussoAlessandra Ghigo
Oct 29, 2020·Oxidative Medicine and Cellular Longevity·Li ZhangLingmei Qian
Jun 25, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Matteo BaucknehtCecilia Marini
Jul 11, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Pushkar Singh RawatUmashanker Navik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.